Published in Cytometry A on October 18, 2012
Mesenchymal stem cell secretome and regenerative therapy after cancer. Biochimie (2013) 0.93
Adult adipose-derived stem cells and breast cancer: a controversial relationship. Springerplus (2014) 0.92
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17
Stem cells, cancer, and cancer stem cells. Nature (2001) 50.27
Tumour evolution inferred by single-cell sequencing. Nature (2011) 19.13
Tumor self-seeding by circulating cancer cells. Cell (2009) 6.66
Cellular origin of cancer: dedifferentiation or stem cell maturation arrest? Environ Health Perspect (1993) 2.30
p53, Stem Cells, and Reprogramming: Tumor Suppression beyond Guarding the Genome. Genes Cancer (2011) 1.54
Regenerative therapy and cancer: in vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates. Tissue Eng Part A (2010) 1.37
Localization of CD44 and CD90 positive cells to the invasive front of breast tumors. Cytometry B Clin Cytom (2010) 1.21
Deconstructing stemness. EMBO J (2005) 1.09
Tumorigenic stem and progenitor cells: implications for the therapeutic index of anti-cancer agents. J Control Release (2007) 1.09
Die hard: are cancer stem cells the Bruce Willises of tumor biology? Cytometry A (2009) 1.06
Tumorigenic epithelial stem cells and their normal counterparts. Ernst Schering Found Symp Proc (2006) 0.99
Stemness as a cell default state. EMBO Rep (2012) 0.94
The stem state: mesenchymal plasticity as a paradigm. Curr Stem Cell Res Ther (2006) 0.94
Large-scale copy number polymorphism in the human genome. Science (2004) 34.64
Strong association of de novo copy number mutations with autism. Science (2007) 27.84
Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics (2004) 24.18
Tumour evolution inferred by single-cell sequencing. Nature (2011) 19.13
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell (2006) 12.72
Annotating large genomes with exact word matches. Genome Res (2003) 11.07
De novo gene disruptions in children on the autistic spectrum. Neuron (2012) 9.69
Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation. Genome Res (2003) 7.86
Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet (2008) 7.13
Inferring tumor progression from genomic heterogeneity. Genome Res (2009) 6.09
Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron (2011) 5.78
An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer. Cell (2008) 5.47
Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron (2011) 4.66
Novel patterns of genome rearrangement and their association with survival in breast cancer. Genome Res (2006) 4.25
A unified genetic theory for sporadic and inherited autism. Proc Natl Acad Sci U S A (2007) 3.47
High definition profiling of mammalian DNA methylation by array capture and single molecule bisulfite sequencing. Genome Res (2009) 3.08
A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions. Proc Natl Acad Sci U S A (2012) 2.85
DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma. Genes Dev (2008) 2.60
Functional identification of tumor-suppressor genes through an in vivo RNA interference screen in a mouse lymphoma model. Cancer Cell (2009) 2.54
Stromal vascular progenitors in adult human adipose tissue. Cytometry A (2010) 2.53
Genome-wide copy number analysis of single cells. Nat Protoc (2012) 2.47
Recurrent DNA copy number variation in the laboratory mouse. Nat Genet (2007) 2.40
Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (ROMA). Blood (2008) 2.35
BRCA1 tumor suppression depends on BRCT phosphoprotein binding, but not its E3 ligase activity. Science (2011) 2.17
A versatile statistical analysis algorithm to detect genome copy number variation. Proc Natl Acad Sci U S A (2004) 1.88
Dosage-dependent phenotypes in models of 16p11.2 lesions found in autism. Proc Natl Acad Sci U S A (2011) 1.82
Prevalence of endogenous CD34+ adipose stem cells predicts human fat graft retention in a xenograft model. Plast Reconstr Surg (2013) 1.70
Dendritic cell subsets in blood and lymphoid tissue of rhesus monkeys and their mobilization with Flt3 ligand. Blood (2003) 1.43
Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck. Cancer Res (2007) 1.40
Regenerative therapy and cancer: in vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates. Tissue Eng Part A (2010) 1.37
DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables. Mol Oncol (2010) 1.33
Rare-event analysis in flow cytometry. Clin Lab Med (2007) 1.20
PROBER: oligonucleotide FISH probe design software. Bioinformatics (2006) 1.20
Adipogenic potential of adipose stem cell subpopulations. Plast Reconstr Surg (2011) 1.19
Application of ROMA (representational oligonucleotide microarray analysis) to patients with cytogenetic rearrangements. Genet Med (2005) 1.15
The contribution of de novo and rare inherited copy number changes to congenital heart disease in an unselected sample of children with conotruncal defects or hypoplastic left heart disease. Hum Genet (2013) 1.15
Human epidermal growth factor receptor 2 testing in gastroesophageal cancer: correlation between immunohistochemistry and fluorescence in situ hybridization. Arch Pathol Lab Med (2011) 1.14
Frequencies of tetramer+ T cells specific for the wild-type sequence p53(264-272) peptide in the circulation of patients with head and neck cancer. Cancer Res (2002) 1.09
Mesenchymal markers on human adipose stem/progenitor cells. Cytometry A (2012) 1.06
Rare event detection and analysis in flow cytometry: bone marrow mesenchymal stem cells, breast cancer stem/progenitor cells in malignant effusions, and pericytes in disaggregated adipose tissue. Methods Mol Biol (2011) 1.06
Distribution of short paired duplications in mammalian genomes. Proc Natl Acad Sci U S A (2004) 1.05
Target inference from collections of genomic intervals. Proc Natl Acad Sci U S A (2013) 1.02
Mouse genomic representational oligonucleotide microarray analysis: detection of copy number variations in normal and tumor specimens. Proc Natl Acad Sci U S A (2006) 1.01
Copy-number variants in patients with a strong family history of pancreatic cancer. Cancer Biol Ther (2007) 0.99
Identification of alterations in DNA copy number in host stromal cells during tumor progression. Proc Natl Acad Sci U S A (2006) 0.99
Activation of human mesenchymal stem cells impacts their therapeutic abilities in lung injury by increasing interleukin (IL)-10 and IL-1RN levels. Stem Cells Transl Med (2013) 0.93
Mesenchymal stem cell secretome and regenerative therapy after cancer. Biochimie (2013) 0.93
Pericytes: a universal adult tissue stem cell? Cytometry A (2011) 0.90
Development and validation of a procedure to isolate viable bone marrow cells from the vertebrae of cadaveric organ donors for composite organ grafting. Cytotherapy (2011) 0.87
Rare de novo germline copy-number variation in testicular cancer. Am J Hum Genet (2012) 0.87
Reducing system noise in copy number data using principal components of self-self hybridizations. Proc Natl Acad Sci U S A (2011) 0.87
Human adipose stromal vascular cell delivery in a fibrin spray. Cytotherapy (2013) 0.83
Statistical classification of multivariate flow cytometry data analyzed by manual gating: stem, progenitor, and epithelial marker expression in nonsmall cell lung cancer and normal lung. Cytometry A (2012) 0.82
Intra-operative preparation of autologous bone marrow-derived CD34-enriched cellular products for cardiac therapy. Cytotherapy (2010) 0.80
KIT (CD117) expression in a subset of non-small cell lung carcinoma (NSCLC) patients. PLoS One (2012) 0.79
Quantitative multigene FISH on breast carcinomas identifies der(1;16)(q10;p10) as an early event in luminal A tumors. Genes Chromosomes Cancer (2014) 0.77
A sense of life: computational and experimental investigations with models of biochemical and evolutionary processes. OMICS (2003) 0.77
Addendum: A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat Cell Biol (2015) 0.76
Corrigendum: Genome-wide copy number analysis of single cells. Nat Protoc (2016) 0.75
Validation of S. pombe sequence assembly by microarray hybridization. J Comput Biol (2006) 0.75